Transpulmonary Thermodilution Measurements in Patients With Heart Diseases

University of Zurich (UZH)

Status and phase

Completed

Phase 4

Conditions

Heart Diseases

Treatments

Device: PiCCO Catheter (Pulsiocath 5F)

Study type

Interventional

Funder types

Other

Identifiers

NCT02035007

Version 2, 17.04.09 / EK1649

Details and patient eligibility

About

The purpose of this study is to examine the validation of the PiCCO (Pulse Contour Cardiac Output)-derived transpulmonary thermodilution technology in patients with heart diseases.

Full description

How do PiCCO and PAC (pulmonary artery catheter) derived hemodynamic variables change in different cardiac pathologies?
How do PiCCO hemodynamic variables compare to transthoracic echocardiographic parameters in different cardiac pathologies?
How does GEDV (global enddiastolic volume) correlate with left ventricles end-diastolic volume (LVEDV) assessed by LV (left ventricle) ventriculography and echocardiography?
How do PiCCO cardiac function variables (GEF [global ejection fraction]; CFI [cardiac function index]) correlate with LV dP/dt max, LVEF (left ventricular ejection fraction) assessed by LV ventriculography and echocardiography, LVFAC (left ventricular fractional area of change), LV stroke work index (LVSWI) and cardiac power (CP)?
How does GEDV compare to LVEDV and left ventricular end-diastolic pressure (LVEDP) as assessed by the pulmonary artery occlusion pressure (PAOP)?
How does right ventricular function influence GEDV, GEF and CFI?

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Coronary heart disease without impaired left ventricular function [LV-EF > 50%] (n=10, control group)
Coronary heart disease with impaired left ventricular function [LV-EF < 50%] (n=10)
Dilated cardiomyopathy (n=10),
Aortic valve stenosis (n=10),
Mitral valve regurgitation (n=10),
Diastolic left ventricular dysfunction (n=10) and
Right heart failure (n=10)

Exclusion criteria

Patients with catecholamine dependent cardiogenic shock, severe respiratory distress because of pulmonary oedema, intubated patients, patients with atrial fibrillation, atrioventricular conduction abnormalities, and slow ventricular tachycardia will not be included.
Moreover patients not being able to give informed consent are excluded. Even more, pregnant women are excluded from the study due to the radiation exposure in line with heart catheterization. A pregnancy test will be performed prior to participating with this study.
The age does not represent an exclusion criterion.